Polymorphism in MTHFR (methylenetetrahydrofolate reductase) gene impacts homocysteine metabolism, which is relevant for patients with CKD because of its role in cardiovascular risk and response to folate intake [98]. This evidence concerns the gene MTHFR and chronic kidney disease.